ESC Premium Access

Initial combination with bosentan and sildenafil as compared with initial monotherapy with the same drugs in patients with pulmonary arterial hypertension: a case-control, multicentre study

Congress Session

About the speaker

Doctor Massimiliano Palazzini

Institute of Cardiology, University of Bologna, Bologna (Italy)
0 follower

15 more presentations in this session

Experience in the pulmonary arterial hypertension management over 30 years: insights of a national reference center.

Speaker: Doctor C. Quezada-Loaiza (Madrid, ES)

Thumbnail

Lung transplantation for pulmonary arterial hypertension, the multidisciplinary approach from an expert center.

Speaker: Doctor C. Quezada-Loaiza (Madrid, ES)

Thumbnail

Factors prohibiting progression to prostanoid therapy in patients with pulmonary arterial hypertension and CTEPH who remain in functional class III or above despite maximal oral therapy

Speaker: Doctor H. Nashat (London, GB)

Thumbnail

Effects of sildenafil in patients with persistent pulmonary hypertension after left prosthetic valvular replacement at rest and during dobutamine stress according to the hemodynamic phenotype

Speaker: Associate Professor J. Aguilar Torres (Madrid, ES)

Thumbnail

Effect of calcium channel blockers on exercise capacity in idiopathic pulmonary arterial hypertension responding to acute pulmonary vasoreactivity testing

Speaker: Mr Y. Tang (Beijing, CN)

Thumbnail

Access the full session

Poster session 3 - Chronic pulmonary hypertension

Speakers: Doctor M. Palazzini, Doctor C. Quezada-Loaiza, Doctor C. Quezada-Loaiza, Doctor H. Nashat, Associate Professor J. Aguilar Torres...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk